RECRUITING

Intestinal Microbiota in Stem Cell Transplant Transplant Admission

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period of Stem cell transplant (SCT) and the rate of overall change in microbiota composition across adjacent samples in time.

Official Title

Intestinal Microbiota Alteration by Antibiotics Used During Stem Cell Transplant Admission

Quick Facts

Study Start:2020-11-03
Study Completion:2026-11-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04623424

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients aged 18-80 years
  2. * patients undergoing allogenic or autologous SCT for malignant hematological conditions or bone marrow failure
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

shatha farhan, MD
CONTACT
313 916 5002
SFARHAN1@HFHS.ORG

Principal Investigator

shatha farhan
PRINCIPAL_INVESTIGATOR
Henry Ford

Study Locations (Sites)

Henry Ford Health System
Detroit, Michigan, 48202
United States

Collaborators and Investigators

Sponsor: Henry Ford Health System

  • shatha farhan, PRINCIPAL_INVESTIGATOR, Henry Ford

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-11-03
Study Completion Date2026-11-03

Study Record Updates

Study Start Date2020-11-03
Study Completion Date2026-11-03

Terms related to this study

Additional Relevant MeSH Terms

  • Stem Cell Transplant Complications